Physician profile
David Roy Stephens
NPI 1023179231
$1,464.26
in general payments reported to CMS, 2019-2025
7 companies · $655 in 2025
The $655 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $61.95 · 2021: $94.08 · 2022: $87.96 · 2023: $142 · 2024: $106 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $466 · Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $466.29 |
| Food and Beverage | $435.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $621.56 | 2024-2025 | |
| Sientra, INC. | $344.45 | 2019-2021 | |
| Abbvie INC. | $243.35 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Allergan, INC. | $189.62 | 2019-2022 | |
| Galderma Laboratories, L.P. | $27.92 | 2022 | |
| Solventum Corporation | $20.85 | 2025 | 3m Cavilon, Activ.A.C., V.A.C. Dermatac |
| Integra Lifesciences Corporation | $16.51 | 2023 | Durasorb Monofilament Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.